Cadre Holdings faces weak organic growth and margin pressures despite M&A activity and long-term potential in niche markets. Find out why CDRE stock is a buy.
Cadre Holdings: Nuclear Is Not A Magic Word (NYSE:CDRE)

127
Cadre Holdings faces weak organic growth and margin pressures despite M&A activity and long-term potential in niche markets. Find out why CDRE stock is a buy.